Press Release

United States Hematology Testing Market to Witness Healthy Growth in Coming Years

Introduction of technologically advanced hematology analyzers to drive United States hematology testing market

According to TechSci Research report, United States Hematology Testing Market By Product Type (Hematology Instruments (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Others), Hematology Consumables (Reagents, Stains, Controls & Calibrators, Others), By Type of Test (Complete Blood Count Analysis, White Blood Cell Analysis, Hemoglobin, Platelet Function, Reticulocytes, Others), By Reagents (Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents, Others), By Application (Anemia, Hemoglobinopathy, leukemia/lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count), By End User (Diagnostic Laboratories, Hospitals, Clinical Testing Laboratories, Academic Institutes, Patient Self-testing, Others), By Region, Forecast & Opportunities, 2025, the market is anticipated to grow at a substantial rate during the forecast period on account of rapid technological advancements in healthcare sector coupled with introduction of more efficient and advanced hematology analyzers. The development of high-sensitivity point-of-care hematology analyzers and increasing usage of flow cytometry in hematology testing is further acting as major growth driver for United States hematology testing market. Additionally, growing prevalence of blood disorders such as thalassemia and increasing awareness about these disorders in United States is also creating high demand for hematology testing. Also, rising patient population and increasing healthcare expenditure are expected to drive the market growth through 2025.

Moreover, companies are coming up with point-of-care devices due to the shifting trend towards patient-self-testing which does not involve travel to a lab, clinic or physicians' office for having the tests done. As more companies are entering in hematology testing, the market is anticipated to grow significantly in coming years. In addition to this, extensive R&D activities and effort by manufacturers to develop cost-effective and advanced hematology systems are propelling the growth of United States hematology testing market.

Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on "United States Hematology Testing Market"

https://www.techsciresearch.com/report/united-states-hematology-testing-market/5118.html

United States hematology testing market is segmented based on product type, type of test, reagents, application, end user and region. Based on product type, the market is segmented into instruments and consumables. Instruments segment is further split into hematology analyzers, flow cytometers, coagulation analyzers and others. Among these, the consumables segment is further categorized into reagents, stains, controls & calibrators and others. Among them, consumables segment is expected to register significant growth in United States hematology testing market on account of rise in diagnosis of blood related disorders and other infections.

Based on type of test, United States hematology testing market can be categorized into complete blood count analysis, white blood cell analysis, hemoglobin, platelet function, reticulocytes and others. Among them, complete blood count analysis is expected to witness robust CAGR in terms of revenue as this test is useful for general evaluation of health during routine check-ups. Complete blood count analysis is also helpful in analyzing conditions such as anemia, vitamin and iron deficiencies, infections and allergies.

Major players operating in the United States hematology testing market include Abbott Laboratories, Inc., Siemens Healthcare Diagnostics Inc., Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, PerkinElmer Inc., Thermo Fisher Scientific Inc., Hoffmann-La Roche Inc., Novo Nordisk, Inc., Fluidigm Corporation and Microfluidics International Corporation. The market players are adopting growth strategies such as mergers and acquisitions, collaborations and new product launches.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=5118

Customers can also request for 10% free customization on this report.

“Increasing number of diagnostic centers in United States is leading to high revenue generation for hematology testing market. The availability of advanced instruments in these labs are further expected to make them dominant end users for hematology testing market. Also, automation has become of the main focus areas for hematology labs as it reduces the cost of these tests, thereby fueling market growth in the country,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.

United States Hematology Testing Market By Product Type (Hematology Instruments (Hematology Analyzers, Flow Cytometers, Coagulation Analyzers, Others), Hematology Consumables (Reagents, Stains, Controls & Calibrators, Others), By Type of Test (Complete Blood Count Analysis, White Blood Cell Analysis, Hemoglobin, Platelet Function, Reticulocytes, Others), By Reagents (Coagulation Reagents, Flow Cytometry Reagents, Immuno-Hematology Reagents, Others), By Application (Anemia, Hemoglobinopathy, leukemia/lymphoma Phenotyping, Hematology Pathophysiology, Complete Blood Count), By End User (Diagnostic Laboratories, Hospitals, Clinical Testing Laboratories, Academic Institutes, Patient Self-testing, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of united States hematology testing market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in United States hematology testing market.

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

 

Tel: +1-646-360-1656

 

Email: [email protected]

Relevant News